NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism

  1. Raquel Sitcheran1,
  2. Patricia C. Cogswell1, and
  3. Albert S. Baldwin, Jr.1,2,3
  1. 1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
  2. 2 Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA

Abstract

Cytokines, such as tumor necrosis factor-α (TNFα), potently inhibit the differentiation of mesenchymal cells and down-regulate the expression of Sox9 and MyoD, transcription factors required for chondrocyte and myocyte development. Previously, we demonstrated that NF-κB controls TNFα-mediated suppression of myogenesis through a mechanism involving MyoD mRNA down-regulation. Here, we show that NF-κB also suppresses chondrogenesis and destabilizes Sox9 mRNA levels. Multiple copies of an mRNA cis-regulatory motif (5′-ACUACAG-3′) are necessary and sufficient for NF-κB-mediated Sox9 and MyoD down-regulation. Thus, in response to cytokine signaling, NF-κB modulates the differentiation of mesenchymal-derived cell lineages via RNA sequence-dependent, posttranscriptional down-regulation of key developmental regulators.

Keywords

Footnotes

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1114503.

  • 3 Corresponding author. E-MAIL jhall{at}med.unc.edu; FAX (919) 966-8212.

    • Accepted July 24, 2003.
    • Received May 19, 2003.
| Table of Contents

Life Science Alliance